Ernexa Therapeutics Inc. short interest in 2025
In 2025, Ernexa Therapeutics Inc.'s disclosed short interest ran from 5.71% of shares outstanding on 31 Jan 2025 to 1.35% on 31 Dec 2025, a change of -4.36 percentage points. The year's high was 6.82% on 14 Mar 2025 and its low 0.49% on 15 Sep 2025, averaging 2.56% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.82 days on 28 Nov 2025. Full history: Ernexa Therapeutics Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 5.71% (31 Jan 2025)
- End of year
- 1.35% (31 Dec 2025)
- Change
- -4.36 pp
- High
- 6.82% (14 Mar 2025)
- Low
- 0.49% (15 Sep 2025)
- Average
- 2.56%
- Highest days to cover
- 3.82 (28 Nov 2025)
- SEC filings marked
- 4
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 31 Jan 2025 | 5.71% | 1.00 | |
| 14 Feb 2025 | 3.45% | 1.00 | |
| 28 Feb 2025 | 6.43% | 1.00 | |
| 14 Mar 2025 | 6.82% | 2.36 | 10-K filed |
| 31 Mar 2025 | 3.90% | 1.00 | |
| 15 Apr 2025 | 3.14% | 1.00 | |
| 30 Apr 2025 | 1.93% | 1.00 | |
| 15 Aug 2025 | 0.64% | 1.57 | 10-Q filed, 10-Q filed |
| 29 Aug 2025 | 0.59% | 1.00 | |
| 15 Sep 2025 | 0.49% | 1.00 | |
| 30 Sep 2025 | 0.72% | 1.00 | |
| 15 Oct 2025 | 0.52% | 1.00 | |
| 14 Nov 2025 | 2.09% | 1.04 | 10-Q filed |
| 28 Nov 2025 | 1.63% | 3.82 | |
| 15 Dec 2025 | 1.51% | 2.10 | |
| 31 Dec 2025 | 1.35% | 2.60 |
See also: Ernexa Therapeutics Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.